We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

6 hedge funds and large institutions have $130K invested in PDL BioPharma, Inc. in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

0% more capital invested

Capital invested by funds: $130K → $130K ($0)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PDLI Hedge Fund Activity: Q3 2023 in Review

6 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2023, worth a combined $130K — unchanged from a quarter earlier.

Fund positioning in PDLI was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 6 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $130K of PDL BioPharma, Inc. stock for Q3 2023, unchanged quarter-over-quarter.
  • 0 funds opened new PDL BioPharma, Inc. positions in Q3 2023 and 0 closed out.

Based on aggregated 13F filings for Q3 2023.